These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 260891)

  • 1. On the effectiveness of treatment for drug abuse: evidence from the DARP research programme in the United States.
    Sells SB; Simpson DD
    Bull Narc; 1979; 31(1):1-11. PubMed ID: 260891
    [No Abstract]   [Full Text] [Related]  

  • 2. The effectiveness of drug treatment.
    Gerstein DR
    Res Publ Assoc Res Nerv Ment Dis; 1992; 70():253-82. PubMed ID: 1311121
    [No Abstract]   [Full Text] [Related]  

  • 3. Recent developments in chemotherapy of narcotic addiction. Part VII. Evaluation of present treatment modalities: research with DARP admissions, 1969-1973.
    Sells SB; Demaree RG; Simpson DD; Joe GW
    Ann N Y Acad Sci; 1978; 311():270-81. PubMed ID: 217292
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment for drug abusers in the United States.
    Nightingale SL
    Addict Dis; 1977; 3(1):11-20. PubMed ID: 930684
    [No Abstract]   [Full Text] [Related]  

  • 5. A cost-effectiveness model for evaluating health care programs: application to drug abuse treatment.
    Goldschmidt PG
    Inquiry; 1976 Mar; 13(1):29-47. PubMed ID: 130347
    [No Abstract]   [Full Text] [Related]  

  • 6. A national follow-up study to evaluate the effectiveness of drug abuse treatment: a report on cohort 1 of the DARP five years later.
    Sells SB; Simpson DD; Joe GW; Demaree RG; Savage LJ; Lloyd MR
    Am J Drug Alcohol Abuse; 1976; 3(4):545-56. PubMed ID: 1032763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Legal status and long-term outcomes for addicts in the DARP followup project.
    Simpson DD; Friend HJ
    NIDA Res Monogr; 1988; 86():81-98. PubMed ID: 3140037
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substance abuse treatment evolves: a follow-up.
    Spath P
    Hosp Peer Rev; 1997 Sep; 22(9):132-4. PubMed ID: 10173140
    [No Abstract]   [Full Text] [Related]  

  • 10. The relation of time spent in drug abuse treatment to posttreatment outcome.
    Simpson DD
    Am J Psychiatry; 1979 Nov; 136(11):1449-53. PubMed ID: 495799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Client evaluations of drug abuse treatment in relation to follow-up outcomes.
    Simpson DD; Lloyd MR
    Am J Drug Alcohol Abuse; 1979; 6(4):397-411. PubMed ID: 549469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug abuse treatment readmissions and outcomes. Three-year follow-up of DARP patients.
    Simpson DD; Savage LJ
    Arch Gen Psychiatry; 1980 Aug; 37(8):896-901. PubMed ID: 7406653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementing methadone medical maintenance in community-based clinics: disseminating evidence-based treatment.
    King VL; Burke C; Stoller KB; Neufeld KJ; Peirce J; Kolodner K; Kidorf M; Brooner RK
    J Subst Abuse Treat; 2008 Oct; 35(3):312-21. PubMed ID: 18294805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome of substance-dependent youth following 12-step treatment.
    Winters KC; Stinchfield R; Latimer WW; Lee S
    J Subst Abuse Treat; 2007 Jul; 33(1):61-9. PubMed ID: 17588490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does psychiatric comorbidity affect drug abuse treatment outcome? A prospective assessment of drug abuse, treatment tenure and infectious diseases in an Israeli methadone maintenance clinic.
    Gelkopf M; Weizman T; Melamed Y; Adelson M; Bleich A
    Isr J Psychiatry Relat Sci; 2006; 43(2):126-36. PubMed ID: 16910375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The treatment of dependence in the therapeutic community].
    Roussaux JP; Ledoux Y; Snoy T; Simonart C; Pelc I
    Acta Psychiatr Belg; 1990; 90(5-6):259-77. PubMed ID: 1670403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prospective study of favorable factors in follow-up of drug addicted patients--apropos of 257 patients of the Cassini Center in Paris].
    Goeb JL; Coste J; Bigot T; Ferrand I
    Encephale; 2000; 26(6):11-20. PubMed ID: 11217533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The quality of highly regarded adolescent substance abuse treatment programs: results of an in-depth national survey.
    Brannigan R; Schackman BR; Falco M; Millman RB
    Arch Pediatr Adolesc Med; 2004 Sep; 158(9):904-9. PubMed ID: 15351757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OEO drug treatment programs.
    Sparer G
    Public Health Rep; 1975; 90(5):455-9. PubMed ID: 809797
    [No Abstract]   [Full Text] [Related]  

  • 20. Outcome evaluation of a prison therapeutic community for substance abuse treatment.
    Wexler HK; Falkin GP; Lipton DS; Rosenblum AB
    NIDA Res Monogr; 1992; 118():156-75. PubMed ID: 1620217
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.